Search Results
50 items found for "Libin Ye"
- FAQ | Dr. GPCR Ecosystem
Yes, everyone interested in the field is welcome to join. The premium membership is priced at $24.99 per month or $249.99 per year. Yes, you can upgrade at any time. Yes, we offer a 30-day free trial for new premium members. If you choose the monthly payment option, you must renew it manually after the first year.
- Dynamic Phosphoproteomics of BRS3 Activation Reveals the Hippo Signaling Pathway for Cell Migration
pathway caused by BRS3 activation could induce the dephosphorylation and nucleus localization of the Yes-associated Authors Miao Guo , Yan Zhang , Lehao Wu , Ye Sheng , Jiaqi Zhao , Zeyuan Wang , Huiyu Wang , Lu Zhang
- Olfactory Receptors and Tumorigenesis: Implications for Diagnosis and Targeted Therapy
Authors Yi Tang, Ye Tian, Chun-Xia Zhang, Guo-Tai Wang Tags G Protein-coupled receptors , Olfactory receptors
- Ep 27 with Dr. Robert J. Lefkowitz
I then pressed record, and we chatted for almost 2h about Bob’s career, discoveries, difficulties (yes
- Activation of orphan receptor GPR132 induces cell differentiation in acute myeloid leukemia
Authors Chunyang Yi, Jiacheng He, Dan Huang, Yumiao Zhao, Chan Zhang, Xiyun Ye, Ying Huang, Ruth Nussinov
- Opposite Effects of Src Family Kinases on YAP and ERK Activation in Pancreatic Cancer Cells: Implications for Targeted Therapy
phosphorylation at Tyr357, as shown by using the SFK inhibitors dasatinib, saracatinib, the preferential YES1 inhibitor CH6953755, siRNA-mediated knockdown of YES1, and transfection of epitogue-tagged YAP mutants , our results also demonstrate that exposure to SFK inhibitors, including dasatinib or knockdown of YES
- Ep 120 with Brendan Wilkins
In his Honours year, Brendan explored small molecule allosteric modulators of the β2-adrenoceptor under Brendan is now a final year PhD candidate in the Orphan Receptor Laboratory headed by Associate Professor
- Classified News | Dr. GPCR Ecosystem
Recorded Courses Exclusive access to early bird special Access to previous events recordings Premium Yearly $ 249.99 249.99$ Every year Immerse yourself into the GPCR World 5 day free trial Start Free Trial Live
- Affiliate Policy | Dr. GPCR Ecosystem
The Affiliate program is only available to individual members who have paid their yearly membership fees
- Registration (private) | Dr. GPCR Ecosystem
Join us at the AGPCR24 Workshop Adhesion Workshop for Industry $ 400 400$ Every year +$12.30 Transaction fee Adhesion GPCR Workshop 2024 + One Year Free Premium Membership Select Adhesion GPCR Workshop 2024 One Year Dr.
- Increased protease-activated receptor 1 autoantibodies are associated with severe COVID-19
Christoph Lange , Jan Rupp , Jan Heyckendorf , Karoline I Gaede , Howard Amital , Philip Rosenstiel , Yehuda
- Ep 125 with Dr. Gregory Tall
They worked on the interactome of yeast and mammalian Rab5 homologs including identification of Rab5
- Exploration of prognostic and treatment markers in hepatocellular carcinoma via GPCR-related genes analysis
Areas under the curves (AUC) corresponding to one-, three- and five-year survival were 0.731, 0.765 and
- Identification of S1PR4 as an immune modulator for favorable prognosis in HNSCC through machine learning
granulocyte colony-stimulating factor, and mitoxantrone (CLAG-M) in a phase 1/2 trial of 81 adults aged ≤60 years One-year overall survival (OS) and EFS were 80% and 76%, without differences in MRD- CR rates, OS, or
- Minireview: functional roles of tissue kallikrein, kinins, and kallikrein-related peptidases in lung cancer
These proteases have been visualized in recent years due to their contribution to the progression of
- G protein-coupled receptors related to autoimmunity in postural orthostatic tachycardia syndrome
In recent years, investigators have described an increased rate of autoimmune comorbidities as evidenced
- University | Dr. GPCR Ecosystem
Recorded Courses Exclusive access to early bird special Access to previous events recordings Premium Yearly $ 249.99 249.99$ Every year Immerse yourself into the GPCR World 5 day free trial Start Free Trial Live
- Single cell G-protein coupled receptor profiling of Transcription factor 21 expressing activated kidney fibroblasts
cells may identify new opportunities for CKD therapeutics. " Authors Harmandeep Kaur , Veera Ganesh Yerra
- Functional Assessment of Cancer-Linked Mutations in Sensitive Regions of Regulators of G Protein Signaling Predicted by Three-Dimensional Missense Tolerance Ratio Analysis
SIGNIFICANCE STATEMENT: Human genetic variant/mutation information has expanded rapidly in recent years
- Metabolic crosstalk: Extracellular ATP and the tumor microenvironment in cancer progression and therapy
extracellular ATP (e-ATP) and ADO effects on the TME poses challenges in identifying optimal treatment targets, yet
- Emerging GPCR targets for AUD: Insights from preclinical studies
Here, we describe the most recent literature, with a primary focus on the past 5 years, on GPCR targets
- The β2-adrenergic receptor associates with CXCR4 multimers in human cancer cells
Authors Junyi Liang , Mohamed Seghiri , Pradeep Kumar Singh , Hyeon Gyu Seo , Ji Yeong Lee , Yoonjung Jo , Yong Bhum Song , Chulo Park , Piotr Zalicki , Jae-Yeon Jeong , Won-Ki Huh , Niña G Caculitan ,
- Ep 105 with Annabelle Milner
As part of the degree, she undertook a 1-year research-based placement at the Charles Perkins Centre Alastair Brown (Sosei Heptares), where she is currently a final year Ph.D. student.
- Involvement of Protease-Activated Receptor2 Pleckstrin Homology Binding Domain in Ovarian Cancer: Expression in Fallopian Tubes and Drug Design
the involvement of G-protein-coupled receptors (GPCRs) in cancer is growing, GPCR-based therapies are yet
- Newsletter Sign Up | Dr. GPCR Ecosystem
GPCR Newsletter We want to bring you closer to what's happening in the GPCR world and yet want to avoid
- Ep 145 with Dr John Janetzko
understanding the mechanism of an enigmatic moonlighting function of OGT that had been described only a year John suggested starting preparations a year to two years ahead due to the time needed to develop ideas
- Ep 141 with Dr Tobi Langenhan
Then I moved to the University of Oxford on a 4-year Wellcome Trust Scholarship in Neuroscience, through
- Ep 55 with Mark Schmeizl
GPCR Podcast << Back to podcast list Mark Schmeizl About Mark Schmeizl Mark leverages 30 years in various